NAMA Policy Statement: Medical Methadone Maintenance”

The National Alliance of Methadone Advocates supports the concept of Medical Maintenance and the prescribing of methadone outside of the methadone clinic setting. Medical Maintenance was initially implemented for patients who had achieved a high level of functionally in society and were hindered by the regulations that were conceived with the dysfunctional patient in mind. Another concern by the designers of Medical Maintenance was the stigma associated with methadone maintenance. The prejudice and misunderstanding of methadone maintenance places the stabilized and fully rehabilitated patient at risk of losing everything they have accomplished if they are seen entering a methadone program. Medical Maintenance can also provide treatment for patients who would not respond well in the program setting and may need specialized treatment that a physician can offer.

Methadone maintenance should be designed to meet the needs of all patients, unfortunately it does not. Medical Maintenance will begin to address these problems. The epidemic of HIV among intravenous drug users creates an urgency to redesign the methadone system to reach all those at risk. At the very least Medical Maintenance will free the fully rehabilitated patient thus opening additional treatment places for those who desperately need methadone treatment.

Since its beginning methadone maintenance has been the most popular treatment for narcotic addiction. Many times over the years methadone treatment had been demonstrated to be the most effective treatment for narcotic addiction, resulting the termination of heroin use and of criminal behavior. In spite of its success, methadone maintenance is often disparaged as a “substitute drug” by those who ignore the positive benefits that it had clearly brought to society. These attitudes negatively impact on methadone maintenance programs in a variety of ways, but it is the methadone patients themselves who are particularly stigmatized and harmed. The atmosphere will not change as long as there is no organization or formal mechanism for methadone patients to voice their own needs and to form a strong unified public presence on their own behalf. As the premier national advocacy organization for methadone treatment the National Alliance of Methadone Advocates, Inc. (NAMA) will actively respond to the issues that affect the daily lives of methadone patients and work towards the day when all methadone patients can take pride in their accomplishments.

Similar Posts

  • Letter

    Admin 08/08/2022

    Letter to the editor Clinch Valley News September 15, 2004 Life Center of Galax opened a clinic in Tazewell County (LCG/T) has helped hundreds of people successfully with Methadone treatment, counseling, and group therapy. The people enrolled in the Life Center and the clinic has been met with scrutiny and stigma based on misunderstanding of…

  • NAMA Needs Volunteers!

    Admin 02/05/2022

    Contact the Executive Director NAMA Recovery needs help with two major things: 1. Website, 2. Funding. Programmers to help with the website. Funding Membership Drives or just asking your program if you can hang up some NAMA Recovery flyers that can bring in new members and of course spread the word about what we do….

  • Write to Your Representatives

    Admin 03/01/2023

    Make This One of Your Monthly Tasks! Write Your Representatives! Write to your representative in Congress and tell them that methadone saved your life and that it works.  You do not have to sign your name you can make up a name like “Mary Methadone” or “Tommy Treatment” and say that you cannot sign your…

  • FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction Drug

    Admin 03/17/2023

    FDA Talk Paper April 20, 2001 T01-15 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The FDA is strengthening warnings to physicians about serious cardiac adverse events associated with Orlaam (levomethadyl acetate HC), a drug for opiate addiction treatment. FDA has changed the Orlaam labeling to increase the strength of the warnings and to…

  • Chicago AATOD October 22, 2010 Training

    Admin 05/27/2022

    Complete Your Training and Certification Download Forms Did you fill out a Registraton Form? If you did not or are not sure then download and send with your Application for CMA and Test. (We need your contact information.) Download Registration (Word2007) Download Registration (PDF) Download the Application and the CMA Test below. Complete both forms and return…

  • Tag: memorial

    Admin 07/18/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…